Amphastar Receives FDA Approval For Regadenoson Following Solid Q1
Multiple Pipeline Launches Expected For H2
Amphastar has become the fifth firm to receive FDA approval for generic regadenoson, but the exact launch date for the firm and its other generic competitors remains uncertain.
